Poor Antibody Response After Two Doses of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccine in Transplant Recipients. (24th June 2021)

• Record Type: Journal Article
• Authors: Mazzola, Alessandra; Todesco, Eve; Drouin, Sarah; Hazan, Fanny; Marot, Stéphane; Thabut, Dominique; Varnous, Shaida; Soulié, Cathia; Barrou, Benoît; Marcelin, Anne-Geneviève; Conti, Filomena
• Is Part Of: Clinical infectious diseases. Volume 74:Number 6(2022)
• Page Start: 1093
• Page End: 1096
• Publication Date: 2021-06-24
• Subjects: SARS-CoV-2 vaccination -- SOT recipients -- humoral response -- COVID-19 disease -- anti-spike antibodies; Communicable diseases -- Periodicals; 616.905
• DOI: 10.1093/cid/ciab580
• Languages: English
• ISSNs: 1058-4838

Abstract

Abstract: A low anti-spike antibody response of 28.6% was observed 28 days after BNT162b2 vaccine second dose among 133 solid organ transplant recipients without previous coronavirus disease 2019 (COVID-19). No serious adverse events were recorded. Four severe COVID-19 cases were reported between or after the 2 doses. Our data suggest to change the vaccine strategy.